INS and type 2 diabetes mellitus: Despite diabetes type II and insulin response having been associated with negative prognosis in COVID-19 patients for different causes, such as associations of pathogenic factors [42,59,60], as well as loss of control and monitoring during the pandemic [61], no ADRs were observed in the diabetic patients, which represented 5.8–7% of our patients in the vaccination program.